Skip to content
Meet the community at CannabisClub.ch.Sign up
CannabisGesetz.chSWISS LAW & POLICY
DEFRITEN
NewsLegislationLaw & regulationPoliticsPilot trialsCantonsPractical guidesLegislative trackerAbout
Home / Law & regulation / Medical cannabis: what changed in 2022?
Current law

Medical cannabis: what changed in 2022?

Since 1 August 2022, prescribing cannabis medicines has no longer required an exceptional FOPH authorisation.

CannabisGesetz.ch editorial deskPublished 7 Nov 2026Reviewed 7 Nov 2026

Context

The amendment concerns medical use. Controlled activities in the supply chain remain subject to the relevant licensing and oversight.

What to check

Coverage is a separate question from whether a medicine can be prescribed. Discuss the proposed treatment and any coverage approval with the relevant professionals.

Official sources

BAG / OFSP / UFSP / FOPH · 01.08.2022 Fedlex · SR 812.121

Related reading

Current law

Swiss cannabis law: the rules in force

The Narcotics Act is the starting point. Medical use and authorised research have separate rules.

Read more
Current law

Cannabis producers: which legal route applies?

Commercial production depends on the intended use and classification of the product.

Read more
Research

How do Swiss cannabis pilot trials work?

Article 8a of the Narcotics Act enables scientific studies limited in place and time.

Read more
CannabisGesetz.ch

An editorial guide to Swiss cannabis law, regulation and policy developments.

Non-government publication · RSS
Editorial policySources and fact checkingContactPrivacyImprintDisclaimer

The contents provide general information and do not replace legal advice. For a specific case, refer to the applicable legislation, decisions and official directions.